Alcohol
Volume 42, Issue 8 , Pages 675-682 , December 2008

Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: a pilot study

  • Irina A. Kirpich

      Affiliations

    • Department of Biochemistry, Northern State Medical University, 161020, Arkhangelsk, Russia
    • Department of Medicine, Division of Gastroenterology/Hepatology, University of Louisville, School of Medicine, 550 South Jackson St., ALB Third Floor, Louisville, KY 40202, USA
  • ,
  • Natalia V. Solovieva

      Affiliations

    • Department of Physiology, Northern State Medical University, 161020, Arkhangelsk, Russia
  • ,
  • Svetlana N. Leikhter

      Affiliations

    • Department of Biochemistry, Northern State Medical University, 161020, Arkhangelsk, Russia
  • ,
  • Natalia A. Shidakova

      Affiliations

    • Department of Biochemistry, Northern State Medical University, 161020, Arkhangelsk, Russia
  • ,
  • Oxsana V. Lebedeva

      Affiliations

    • Department of Microbiology, Virology, and Immunology, Northern State Medical University, 161020, Arkhangelsk, Russia
  • ,
  • Pavel I. Sidorov

      Affiliations

    • Department of Drug and Alcohol Center, Northern State Medical University, 161020, Arkhangelsk, Russia
  • ,
  • Tatjana A. Bazhukova

      Affiliations

    • Department of Microbiology, Virology, and Immunology, Northern State Medical University, 161020, Arkhangelsk, Russia
  • ,
  • Andrej G. Soloviev

      Affiliations

    • Department of Drug and Alcohol Center, Northern State Medical University, 161020, Arkhangelsk, Russia
  • ,
  • Shirish S. Barve

      Affiliations

    • Department of Medicine, Division of Gastroenterology/Hepatology, University of Louisville, School of Medicine, 550 South Jackson St., ALB Third Floor, Louisville, KY 40202, USA
  • ,
  • Craig J. McClain

      Affiliations

    • Department of Medicine, Division of Gastroenterology/Hepatology, University of Louisville, School of Medicine, 550 South Jackson St., ALB Third Floor, Louisville, KY 40202, USA
    • Jewish Hospital of Louisville, KY USA
    • Department of Veterans Affairs, Louisville VA Medical Center, Louisville, KY USA
    • Corresponding Author InformationCorresponding author. Tel.: +1-502-852-6128; fax: +1-502-852-8927.
  • ,
  • Matt Cave

      Affiliations

    • Department of Medicine, Division of Gastroenterology/Hepatology, University of Louisville, School of Medicine, 550 South Jackson St., ALB Third Floor, Louisville, KY 40202, USA
    • Jewish Hospital of Louisville, KY USA
    • Department of Veterans Affairs, Louisville VA Medical Center, Louisville, KY USA

Received 27 May 2008 ,Revised 22 July 2008 ,Accepted 9 August 2008.

References 

  1. Adawi D, Ahrne S, Molin G. Effects of different probiotic strains of Lactobacillus and Bifidobacterium on bacterial translocation and liver injury in an acute liver injury model. Int. J. Food Microbiol. 2001;70:213–220
  2. Adawi D, Kasravi FB, Molin G, Jeppsson B. Effect of Lactobacillus supplementation with and without arginine on liver damage and bacterial translocation in an acute liver injury model in the rat. Hepatology. 1997;25:642–647
  3. Boirivant M, Strober W. The mechanism of action of probiotics. Curr. Opin. Gastroenterol. 2007;23:679–692
  4. Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes. 2007;56:1761–1772
  5. Cani PD, Delzenne NM. Gut microflora as a target for energy and metabolic homeostasis. Curr. Opin. Clin. Nutr. Metab. Care. 2007;10:729–734
  6. Cani PD, Neyrinck AM, Fava F, Knauf C, Burcelin RG, Tuohy KM, et al. Selective increases of Bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia. 2007;50:2374–2383
  7. Carithers RL, McClain CM. Alcoholic liver disease. In:  Feldman M,  Friedman L,  Brandt L editor. Sleisenger and Fordtran's Gastrointestinal and Liver Disease Pathophysiology/Diagnosis/Management. Canada: Saunders Elsevier; 2006;p. 1771–1792
  8. Chiva M, Soriano G, Rochat I, Peralta C, Rochat F, Llovet T, et al. Effect of Lactobacillus johnsonii La1 and antioxidants on intestinal flora and bacterial translocation in rats with experimental cirrhosis. J. Hepatol. 2002;37:456–462
  9. D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J. Hepatol. 2006;44:217–231
  10. Daubioul CA, Horsmans Y, Lambert P, Danse E, Delzenne NM. Effects of oligofructose on glucose and lipid metabolism in patients with nonalcoholic steatohepatitis: results of a pilot study. Eur. J. Clin. Nutr. 2005;59:723–726
  11. Daubioul CA, Taper HS, De Wispelaere LD, Delzenne NM. Dietary oligofructose lessens hepatic steatosis, but does not prevent hypertriglyceridemia in obese zucker rats. J. Nutr. 2000;130:1314–1319
  12. Delzenne NM, Cani PD, Neyrinck AM. Modulation of glucagon-like peptide 1 and energy metabolism by inulin and oligofructose: experimental data. J. Nutr. 2007;137:2547S–2551S
  13. Dumas ME, Barton RH, Toye A, Cloarec O, Blancher C, Rothwell A, et al. Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice. Proc. Natl. Acad. Sci. U. S. A. 2006;103:12511–12516
  14. Elinav E, Pappo O, Sklair-Levy M, Margalit M, Shibolet O, Gomori M, et al. Amelioration of non-alcoholic steatohepatitis and glucose intolerance in ob/ob mice by oral immune regulation towards liver-extracted proteins is associated with elevated intrahepatic NKT lymphocytes and serum IL-10 levels. J. Pathol. 2006;208:74–81
  15. Ewaschuk J, Endersby R, Thiel D, Diaz H, Backer J, Ma M, et al. Probiotic bacteria prevent hepatic damage and maintain colonic barrier function in a mouse model of sepsis. Hepatology. 2007;46:841–850
  16. Gionchetti P, Rizzello F, Venturi A, Brigidi P, Matteuzzi D, Bazzocchi G, et al. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology. 2000;119:305–309
  17. Han SY, Huh CS, Ahn YT, Lim KS, Baek YJ, Kim DH. Hepatoprotective effect of lactic acid bacteria, inhibitors of beta-glucuronidase production against intestinal microflora. Arch. Pharmacol. Res. 2005;28:325–329
  18. Hart AL, Lammers K, Brigidi P, Vitali B, Rizzello F, Gionchetti P, et al. Modulation of human dendritic cell phenotype and function by probiotic bacteria. Gut. 2004;53:1602–1609
  19. Hassan MM, Hwang LY, Hatten CJ, Swaim M, Li D, Abbruzzese JL, et al. Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus. Hepatology. 2002;36:1206–1213
  20. Kalliomaki M, Collado MC, Salminen S, Isolauri E. Early differences in fecal microbiota composition in children may predict overweight. Am. J. Clin. Nutr. 2008;87:534–538
  21. Keshavarzian A, Choudhary S, Holmes EW, Yong S, Banan A, Jakate S, et al. Preventing gut leakiness by oats supplementation ameliorates alcohol-induced liver damage in rats. J. Pharmacol. Exp. Ther. 2001;299:442–448
  22. Kim WR, Brown RS, Terrault NA, El-Serag H. Burden of liver disease in the United States: summary of a workshop. Hepatology. 2002;36:227–242
  23. Kirpich IA, Bazhukova TA, Simonova GN, Lebedeva OV, Sidorov PI, Solov'ev AG. Colon micro flora of patients with chronic alcoholism. News science technique. Alcohol. Dis. 2000;8:1–4
  24. Lam EK, Tai EK, Koo MW, Wong HP, Wu WK, Yu L, et al. Enhancement of gastric mucosal integrity by Lactobacillus rhamnosus GG. Life Sci. 2007;80:2128–2136
  25. Lin MY, Chang FJ. Antioxidative effect of intestinal bacteria Bifidobacterium longum ATCC 15708 and Lactobacillus acidophilus ATCC 4356. Dig. Dis. Sci. 2000;45:1617–1622
  26. Liu Q, Duan ZP, Ha DK, Bengmark S, Kurtovic J, Riordan SM. Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology. 2004;39:1441–1449
  27. Li Z, Yang S, Lin H, Huang J, Watkins PA, Moser AB, et al. Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease. Hepatology. 2003;37:343–350
  28. Loguercio C, Federico A, Tuccillo C, Terracciano F, D'Auria MV, De Simone C, et al. Beneficial effects of a probiotic VSL#3 on parameters of liver dysfunction in chronic liver diseases. J. Clin. Gastroenterol. 2005;39:540–543
  29. McClain CJ, Barve S, Deaciuc I, Kugelmas M, Hill D. Cytokines in alcoholic liver disease. Semin. Liver Dis. 1999;19:205–219
  30. McClain CJ, Cohen DA. Increased tumor necrosis factor production by monocytes in alcoholic hepatitis. Hepatology. 1989;9:349–351
  31. McFarland LV, Surawicz CM, Greenberg RN, Fekety R, Elmer GW, Moyer KA, et al. A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. J. Am. Med. Assoc. 1994;271:1913–1918
  32. Nanji AA, Khettry U, Sadrzadeh SM. Lactobacillus feeding reduces endotoxemia and severity of experimental alcoholic liver (disease). Proc. Soc. Exp. Biol. Med. 1994;205:243–247
  33. Osman N, Adawi D, Ahrne S, Jeppsson B, Molin G. Probiotics and blueberry attenuate the severity of dextran sulfate sodium (DSS)-induced colitis. Dig. Dis. Sci. 2008;53:2464–2473
  34. Riordan SM, Skinner N, Nagree A, McCallum H, McIver CJ, Kurtovic J, et al. Peripheral blood mononuclear cell expression of toll-like receptors and relation to cytokine levels in cirrhosis. Hepatology. 2003;37:1154–1164
  35. Takeda K, Suzuki T, Shimada SI, Shida K, Nanno M, Okumura K. Interleukin-12 is involved in the enhancement of human natural killer cell activity by Lactobacillus casei Shirota. Clin. Exp. Immunol. 2006;146:109–115
  36. Wakim-Fleming J, Mullen KD. Long-term management of alcoholic liver disease. Clin. Liver Dis. 2005;9:135–149
  37. Zhao HY, Wang HJ, Lu Z, Xu SZ. Intestinal microflora in patients with liver cirrhosis. Chin. J. Dig. Dis. 2004;5:64–67

PII: S0741-8329(08)00301-7

doi: 10.1016/j.alcohol.2008.08.006

Alcohol
Volume 42, Issue 8 , Pages 675-682 , December 2008